Using phecodes for research with the electronic health record: from PheWAS to PheRS

L Bastarache - Annual review of biomedical data science, 2021 - annualreviews.org
Electronic health records (EHRs) are a rich source of data for researchers, but extracting
meaningful information out of this highly complex data source is challenging. Phecodes …

Practical guide for managing large-scale human genome data in research

T Tanjo, Y Kawai, K Tokunaga, O Ogasawara… - Journal of Human …, 2021 - nature.com
Studies in human genetics deal with a plethora of human genome sequencing data that are
generated from specimens as well as available on public domains. With the development of …

[HTML][HTML] Returning integrated genomic risk and clinical recommendations: The eMERGE study

JE Linder, A Allworth, HT Bland, PJ Caraballo… - Genetics in …, 2023 - Elsevier
Purpose Assessing the risk of common, complex diseases requires consideration of clinical
risk factors as well as monogenic and polygenic risks, which in turn may be reflected in …

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

Y Gupta, DJ Friedman, MT McNulty, A Khan… - Nature …, 2023 - nature.com
African Americans have a significantly higher risk of develo** chronic kidney disease,
especially focal segmental glomerulosclerosis-, than European Americans. Two coding …

[HTML][HTML] Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference

A Köttgen, E Cornec-Le Gall, J Halbritter, K Kiryluk… - Kidney international, 2022 - Elsevier
Numerous genes for monogenic kidney diseases with classical patterns of inheritance, as
well as genes for complex kidney diseases that manifest in combination with environmental …

[HTML][HTML] Frequency of genomic secondary findings among 21,915 eMERGE network participants

AS Gordon, H Zouk, E Venner, CM Eng, BH Funke… - Genetics in …, 2020 - Elsevier
Purpose Discovering an incidental finding (IF) or secondary finding (SF) is a potential result
of genomic testing, but few data exist describing types and frequencies of SFs likely to …

Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization

CLB Zawatsky, N Shah, K Machini, E Perez… - The American Journal of …, 2021 - cell.com
Over 100 million research participants around the world have had research array-based
genoty** (GT) or genome sequencing (GS), but only a small fraction of these have been …

Association of pathogenic variants in hereditary cancer genes with multiple diseases

C Zeng, LA Bastarache, R Tao, E Venner… - JAMA …, 2022 - jamanetwork.com
Importance Knowledge about the spectrum of diseases associated with hereditary cancer
syndromes may improve disease diagnosis and management for patients and help to …